What is the most appropriate first‑line proton‑pump inhibitor for epigastric pain associated with dyspepsia in an adult patient?

Best PPI for Epigastric Pain in Dyspepsia

Any standard-dose PPI (omeprazole 20 mg, lansoprazole 30 mg, pantoprazole 40 mg, or rabeprazole 20 mg) taken once daily 30-60 minutes before a meal is appropriate first-line therapy, as all commercially available PPIs are functionally equivalent when dosed appropriately for dyspepsia. 1

First-Line Treatment Approach

PPIs are strongly recommended as first-line empirical therapy for functional dyspepsia, demonstrating superiority over placebo, H2-receptor antagonists, and antacid combinations. 2, 3

Specific Dosing Recommendations

• Start with standard-dose PPI once daily for 4-8 weeks (omeprazole 20 mg, lansoprazole 30 mg, pantoprazole 40 mg, or rabeprazole 20 mg) 1, 3
• Take 30-60 minutes before a meal for optimal acid suppression 1, 3
• There is no dose-response relationship, so use the lowest effective dose 1

Evidence Supporting PPI Efficacy

The British Society of Gastroenterology (2022) provides a strong recommendation based on high-quality evidence that PPIs are efficacious for functional dyspepsia, with a number needed to treat of 11. 2 A Cochrane meta-analysis of 18 trials involving 6,172 participants confirmed PPIs reduce dyspepsia symptoms compared to placebo (RR 0.88,95% CI 0.82-0.94). 4

For ulcer-like dyspepsia with epigastric pain as the predominant symptom, full-dose PPI therapy is the first choice. 1, 3 Studies specifically evaluating pantoprazole 20 mg and omeprazole 20 mg in ulcer-like functional dyspepsia showed 54-58% complete symptom relief versus 23-27% with placebo. 5, 6

H. Pylori Testing is Mandatory First

Test all patients for H. pylori using urea breath test or stool antigen before or concurrent with PPI initiation; eradicate if positive. 1, 3 Eradication therapy is strongly recommended based on high-quality evidence, though adverse events are more common than control therapy. 2

Treatment Escalation Algorithm

If symptoms persist after initial therapy:

1. Escalate to twice-daily PPI dosing (morning and evening before meals) for an additional 4-8 weeks 1, 3
2. If symptoms persist despite twice-daily PPI for 8 weeks total, proceed to upper endoscopy 1, 3
3. Consider tricyclic antidepressants (amitriptyline 10 mg once daily, titrated to 30-50 mg) as second-line therapy (strong recommendation, moderate-quality evidence) 2, 3

Important Clinical Caveats

PPIs may have little or no additional benefit in dysmotility-like dyspepsia (early satiety, bloating, fullness predominant), though they remain first-line treatment. 4, 5 In these cases, consider adding a prokinetic agent after adequate PPI trial. 1, 3

Avoid long-term PPI use without documented indication. Once symptoms are controlled, taper to the lowest effective dose or consider on-demand therapy. 1 Most patients with functional dyspepsia have nonerosive disease and should be considered for de-prescribing after symptom control. 1

All PPIs are well-tolerated with similar adverse event profiles to placebo. 2, 4, 6

Adjunctive Measures

Advise all patients to take regular aerobic exercise (strong recommendation). 2, 3 There is insufficient evidence to recommend specific dietary therapies including low-FODMAP diets. 2